Bourla said Pfizer could be ready to file for U.S. regulatory approval for a redesigned vaccine and launch it as soon as March
11 Jan 2022 10:31 AM
The companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch
16 Nov 2021 1:02 PM
Older Americans and other groups particularly vulnerable to the virus have had access to a third dose of the Pfizer and BioNTech vaccine
10 Nov 2021 11:40 AM
The results from the clinical trial are so good that Pfizer will stop recruiting new people for the trial, the company said
05 Nov 2021 5:44 PM
The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old
29 Sep 2021 9:16 AM
Ongoing follow-up is needed to understand the persistence of the vaccine effect over time
29 Jul 2021 9:34 AM
The participants were pre-screened to ensure they had no underlying fertility issues
18 Jun 2021 4:07 PM
Pfizer vaccine offered 92 per cent protection against the Alpha variant and 79 per cent against the Delta strain 2 weeks after the 2nd dose
15 Jun 2021 1:11 PM
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) today announced this decision
04 Jun 2021 6:00 PM
Owing to the evolution of the coronavirus, scientists have called for the continuous monitoring of changes in the virus for vaccine coverage
09 Jan 2021 4:38 AM